Sweet role of platelet endothelial cell adhesion molecule in understanding angiogenesis

Glycobiology

Volumn 24, Issue 12, 2014, Pages 1260-1264

  Kitazume, Shinobu ^a   Imamaki, Rie ^a   Ogawa, Kazuko ^a   Taniguchi, Naoyuki ^a  

^a RIKEN   (Japan)

Author keywords

Angiogenesis; Lectin; PECAM; Sialic acid; ST6Gal I

Indexed keywords

ALPHA2,6 SIALIC ACID; CD31 ANTIGEN; GLYCAN; LECTIN; SIALIC ACID; SIALYLTRANSFERASE; UNCLASSIFIED DRUG;

ANGIOGENESIS; BIOLOGICAL ACTIVITY; CELL ADHESION; CELL SURVIVAL; CHEMICAL STRUCTURE; ENDOTHELIUM CELL; GLYCOCALYX; HUMAN; MECHANICAL STRESS; MECHANOSENSOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; METABOLISM;

ANTIGENS, CD31; HUMANS; LECTINS; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 84925632944     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwu094     Document Type: Review

References (36)

1. Abe Y, Smith CW, Katkin JP, Thurmon LM, Xu X, Mendoza LH, Ballantyne CM. 1999. Endothelial alpha 2,6-linked sialic acid inhibits VCAM-1-dependent adhesion under flow conditions. J Immunol. 163:2867-2876.
2. Bird IN, Taylor V, Newton JP, Spragg JH, Simmons DL, Salmon M, Buckley CD. 1999. Homophilic PECAM-1(CD31) interactions prevent endothelial cell apoptosis but do not support cell spreading or migration . J Cell Sci. 112 (Pt 12):1989-1997.
3. Blixt O, Head S, Mondala T, Scanlan C, Huflejt ME, Alvarez R, Bryan MC, Fazio F, Calarese D, Stevens J, et al. 2004. Printed covalent gly can array for ligand profiling of diverse glycan binding proteins. Proc Natl Acad Sci USA. 101:17033-17038.
4. Born GV, PalinskiW. 1985. Unusually high concentrations of sialic acids on the surface of vascular endothelia. Br J Exp Pathol. 66:543-549.
5. Buckley CD, Doyonnas R, Newton JP, Blystone SD, Brown EJ, Watt SM, Simmons DL. 1996. Identification of alpha v beta 3 as a heterotypic ligand for CD31/PECAM-1. J Cell Sci. 109(Pt 2):437-445.
6. Cioffi DL, Pandey S, Alvarez DF, Cioffi EA. 2012. Terminal sialic acids are an important determinant of pulmonary endothelial barrier integrity. Am J Physiol Lun g Cell Mol Physiol. 302:L1067-L1077.
7. Croci DO, Cerliani JP, Dalotto-Moreno T, Mendez-Huergo SP, Mascanfroni ID, Dergan-Dylon S, Toscano MA, Caramelo JJ, Garcia-Vallejo JJ, Ouyang J, et al. 2014. Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors. Cell. 156:744-758.
8. Crocker PR, Paulson JC, Varki A. 2007. Siglecs and their roles in the immune system. Nat Rev Immunol. 7:255-266.
9. Cross AS, Hyun SW, Miranda-Ribera A, Feng C, Liu A, Nguyen C, Zhang L, Luzina IG, Atamas SP, Twaddell WS, et al. 2012. NEU1 and NEU3 sialidase activity expressed in human lung microvascular endothelia: NEU1 restrains endothelial cell migration, whereas NEU3 does not. J Biol Chem. 287:15966-15980.
10. Deaglio S, Morra M, Mallone R, Ausiello CM, Prager E, Garbarino G, Dianzani U, Stockinger H, Malavasi F. 1998. Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. J Immunol. 160:395-402.
11. Gao C, Sun W, Christofidou-Solomidou M, Sawada M, Newman DK, Bergom C, Albelda SM, Matsuyama S, Newman PJ. 2003. PECAM-1 functions as a specific and potent inhibitor of mitochondrial-dependent apoptosis. Blood. 102:169-179.
12. Geyer H, Geyer R, Odenthal-Schnittler M, Schnittler HJ. 1999. Characterization of human vascular endothelial cadherin glycans. Glycobiology. 9:915-925.
13. Grewal PK, Uchiyama S, Ditto D, Varki N, Le DT, Nizet V, Marth JD. 2008. The Ashwell receptor mitigates the lethal coagulopathy of sepsis. Nat Med. 14:648-655.
14. Hanasaki K, Varki A, Powell LD. 1995. CD22-mediated cell adhesion to cytokine-Activated human endothelial cells. Positive and negative regulation by alpha 2-6-sialylation of cellular glycoproteins. J Biol Chem. 270:7533-7542.
15. Hanasaki K, Varki A, Stamenkovic I, Bevilacqua MP. 1994. Cytokine-induced beta-galactoside alpha-2,6-sialyltransferase in human endothelial cells mediates alpha 2,6-sialylation of adhesion molecules and CD2 2 ligands. J Biol Chem. 269:10637-10643.
16. Kitazume S, Imamaki R, Kurimoto A, Ogawa K, Kato M, Yamaguchi Y, Tanaka K, Ishida H, Ando H, Kiso M, et al. 2014. Interaction of pla telet endothelial cell adhesion molecule (PECAM) with alpha2,6-sialylated glycan regulates its cell surface residency and anti-Apoptotic role. J Biol Chem. 289:Epub ahead of print.
17. Kitazume S, Imamaki R, Ogawa K, Komi Y, Futakawa S, Kojima S, Hashimoto Y, Marth JD, Paulson JC, Taniguchi N. 2010. Alpha2,6-sialic acid on platelet endothelial cell adhesion molecule (PECAM) regulates its homophilic interactions and downstream antiap optotic signaling. J BiolChem. 285:6515-6521.
18. Lee C,Liu A,Miranda-Ribera A,Hyun SW,Lillehoj EP,Cross AS,Passaniti A,Grimm PR,Kim BY,Welling PA,et al. 2014 NEU1 sia lidase regulates the sialylation state of CD31 and disrupts CD31-driven capillary-like tube formation in human lung microvascular endothelia J Biol Chem. 289 9121-9135.
19. Lundquist JJ, Toone EJ. 2002. The cluster glycoside effect. Chem Rev. 102:555-578.
20. Newman PJ, Berndt MC, Gorski J, White GC, II, Lyman S, Paddock C, Muller WA. 1990. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science. 247:1219-1222.
21. Newman PJ, Newman DK. 2003. Signal transduction pathways mediated by PECAM-1: New roles for an old molecule in platelet and vascular cell biology. Arterioscler Thromb Vasc Biol. 23:953-964.
22. Newton JP, Buckley CD, Jones EY, Simmons DL. 1997. Residues on both faces of the first immunoglobulin fold contribute to homophilic binding sites of PECAM-1/CD31. J Biol Chem. 272:20555-20563.
23. Nitschke L, Floyd H, Ferguson DJ, Crocker PR. 1999. Identification of CD22 ligands on bone marrow sinusoidal endothelium implicated in CD22-dependent homing of recirculating B cells. J Exp Med. 189:1513-1518.
24. Noble KE, Wickremasinghe RG, DeCornet C, Panayiotidis P, Yong KL. 1999. Monocytes stimulate expression of the Bcl-2 family member, A1, in endothelial cells a nd confer protection against apoptosis. J Immunol. 162:1376-1383.
25. Park S, DiMaio TA, Scheef EA, Sorenson CM, Sheibani N. 2010. PECAM-1 regulates proangiogenic properties of endothelial cells throug h modulation of cell-cell and cell-matrix interactions. Am J Physiol Cell Physiol. 299: C1468-C1484.
26. Piali L, Hammel P, Uherek C, Bachmann F, Gisler RH, Dunon D, Imhof BA. 1995. CD31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion of leukocytes to endothelium. J Cell Biol. 130:451-460.
27. Rosen SD, Chi SI, True DD, Singer MS, Yednock TA. 1989. Intravenously injected s ialidase inactivates attachment sites for lymphocytes on high endothelial venules. J Immunol. 142:1895-1902.
28. Sachs UJ, Andrei-Selmer CL, Maniar A, Weiss T, Paddock C, Orlova VV, Choi EY, Newman PJ, Preissner KT, Chavakis T, et al. 2007. The neutrophilspecific antigen CD177 is a counter-receptor for platele t endothelial cell adhesion molecule-1 (CD31). J Biol Chem. 282:23603-23612.
29. Scott DW, Dunn TS, Ballestas ME, Litovsky SH, Patel RP. 2013. Identification of a high-mannose ICAM-1 glycoform: Effects of ICAM-1 hypoglycosylation on monocyte adhesion and outside in signaling. Am J Physiol Cell Physiol. 305:C228-C237.
30. Simmons DL, Walker C, Power C, Pigott R. 1990. Molecular cloning of CD31, a putative intercellular adhesion molecule closely related to carcinoembryonic antigen. J Exp Med. 171:2147-2152.
31. Sorensen AL, Rumjantseva V, Nayeb-Hashemi S, Clausen H, Hartwig JH, Wandall HH, Hoffmeister KM. 2009. Role of sialic acid for platelet life span: Exposure of beta-galactose results in the rapid clearance of platelets from the circulation by asialoglycoprotein receptor-expressing liver macrophages and hepatocytes. Blood. 114:1645-1654.
32. Stockinger H, Gadd SJ, Eher R, Majdic O, Schreiber W, Kasinrerk W, Strass B, Schnabl E, Knapp W. 1990. Molecular characterization and functional analysis of the leukocyte surface protein CD31. J Immunol. 145:3889-3897.
33. Toscano MA, Bianco GA, Ilarregui JM, Croci DO, Correale J, Hernandez JD, Zwirner NW, Poirier F, Riley EM, Baum LG, et al. 2007. Differential g lycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat Immunol. 8:825-834.
34. Tzima E, Irani-Tehrani M, Kiosses WB, Dejana E, Schultz DA, Engelhardt B, Cao G, DeLisser H, Schwartz MA. 2005. A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature. 437:426-431.
35. Wong CW, Wiedle G, Ballestrem C, Wehrle-Ha ller B, Etteldorf S, Bruckner M, Engelhardt B, Gisler RH, Imhof BA. 2000. PECAM-1/CD31 transhomophilic binding at the intercellular junctions is independent of its cytoplasmic domain; evidence for heterophilic interaction with integrin alphavbeta3 in Cis. Mol Biol Cell. 11:3109-3121.
36. Woodfin A, Voisin MB, Nourshargh S. 2007. PECAM-1: A multi-functional molecule in inflammation and vascular biology. Arterioscler Thromb Vasc Biol. 27:2514-2523.